08:00 Thu 16 Apr 2020
Volex PLC - Trading Update
("Volex" or the "Company")
Trading Update
· The Company reiterates current guidance for the financial year ended
· Full-year sales expected to exceed
· Net cash as at
· Looking ahead, it appears likely that economic activity and consequently trading will be impacted by restrictive governmental measures put in place to contain the spread of Covid-19. However, the quantum and precise impact will depend on the length of time such measures are in place and their severity, offset against our defensive exposure to medical devices and data-centre products, which make up approximately two-thirds of our complex assemblies division;
· Our medical sites have been assigned "essential business" status in the US and
"The worldwide COVID-19 pandemic is forcing governments to implement extreme, restrictive measures in an attempt to curb the spread of the virus. Our priorities are first and foremost: to safeguard the health and safety of our employees and our local communities; where possible to support government actions to slow the spread of COVID-19; and to assess and mitigate the risks to our business continuity.
However, despite this 'perfect storm', Volex's business has proved remarkably resilient, continuing to produce a solid performance in both sales and operating margins. Our strategy to diversify our products, customers and geographic footprint, together with our exposure to medical devices (and high-speed data centre products, which are in even greater demand as much of the world's population works from home), has resulted in continued growth and strong cash generation, despite significant headwinds.
In order to mitigate any unforeseen financial impact should the macroeconomic outlook deteriorate further, the group is taking steps to optimise cash flow. However, we have today announced a recommended final dividend of
We are closely monitoring all available forms of relief from governments on direct and indirect taxes, social charges, and employee relief funds, and assessing their relevance to Volex. Current headroom under our existing facility, combined with our cash balances, provides the group with circa $60 million of liquidity and, in line with our strategy, our team continues to actively look for new opportunities to grow our business and technical capabilities.
Operationally, there remain substantial identifiable opportunities for both divisions to improve sales and margin performance through disciplined execution of our strategy, in both the short and longer term. While the duration and impact of the COVID-19 virus remains uncertain, we remain confident that Volex will continue to progress in the year ahead.
We thank all of our customers, suppliers and employees for their dedication and commitment at this difficult time."
This announcement, released by
For further information please contact:
|
+44 7909 995 887 |
|
|
|
|
N+1 Singer - Nominated Adviser & Joint Broker |
+44 20 7496 3000 |
|
|
|
|
|
+44 20 7659 1234 |
|
|
|
|
This information is provided by RNS, the news service of the
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE